US Patent 9089604 Modified polynucleotides for treating galactosylceramidase protein deficiency
Patent 9089604 was granted and assigned to Moderna Therapeutics on July, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9089604 Modified polynucleotides for treating galactosylceramidase protein deficiency
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.